Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 04 - 28 tags : Biotechnology save search
Cellectis Publishes Two Articles in Nature Communications Providing Strong Preclinical Validation of UCART123 to Treat AML and BPDCN
Published: 2022-04-28 (Crawled : 19:00) - biospace.com/
CLLS | $2.47 0.41% 0.4% 15K
|
Health Technology
|
| O: -1.31%
H: 0.53%
C: -3.7%
ucart123 preclinical aml communications pre-clinical
Jasper Therapeutics Announces Plans for Registrational Study of JSP191 in Older Patients with Myelodysplastic Syndromes or Acute Myeloid Leukemia Undergoing Hematopoietic Cell Transplantation after Type C FDA Meeting
Published: 2022-04-28 (Crawled : 19:00) - biospace.com/
JSPR | $23.21 -2.56% -2.32% 120K
|
|
| O: 16.64%
H: 0.0%
C: -17.18%
jsp191 fda leukemia therapeutics order acute myeloid leukemia
Alzamend Neuro Announces $4 Million Additional Investment from Digital Power Lending Upon Completion of Phase 1 First-in-Human Clinical Trial for AL001 Treatment of Dementia Related to Alzheimer’s
Published: 2022-04-28 (Crawled : 11:00) - biospace.com/
NILE 4 | $0.1225 0.0%
|
n/a
|
| O: -2.93%
H: 3.88%
C: 0.64%
ALZN | $0.691 -4.57% -4.79% 130
|
Professional, Scientific, and T...
|
| O: 5.59%
H: 1.6%
C: -2.25%
al001 treatment dementia trial alzheimer’s phase 1 alzheimer's
BitNile Holdings Announces Additional Investment in Alzamend From Completion of Phase 1 First-in-Human Clinical Trial for AL001 Treatment of Dementia Related to Alzheimer’s
Published: 2022-04-28 (Crawled : 11:00) - biospace.com/
NILE 4 | $0.1225 0.0%
|
n/a
|
| O: -2.93%
H: 3.88%
C: 0.64%
ALZN | $0.691 -4.57% -4.79% 130
|
Professional, Scientific, and T...
|
| O: 5.59%
H: 1.6%
C: -2.25%
al001 treatment dementia trial alzheimer’s phase 1 alzheimer's
OMass Therapeutics Raises $100 Million in Series B Financing to Progress Drug Pipeline in Immunology and Rare Diseases
Published: 2022-04-28 (Crawled : 10:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -2.96%
H: 0.0%
C: 0.0%
SNY | News | $45.39 -1.56% -1.58% 4.3M
|
Health Technology
|
| O: -2.36%
H: 0.0%
C: 0.0%
rare drug immunology therapeutics disease
Gainers vs Losers
| 58% | 42% |
Top 10 Gainers
ZCMD | $1.45 5.84% 49.63% 15M
|
Commercial Services
AULT | $0.2421 -7.7% 45.23% 16M
|
Manufacturing
XPON | News | $3.15 63.21% 33.9% 100K
|
EGOX | $0.036 12.15% 31.56% 32M
|
TIRX | $0.8 65.02% 25.95% 410K
|
VTNR 4 | $1.31 33.78% 25.82% 220K
|
Industrial Services
GDHG | $0.263 21.76% 25.34% 1.3M
|
TPET | $0.3279 -3.56% 23.57% 11M
|
n/a
HOLO | $2.95 31.7% 22.49% 37M
|
MTNB | $0.19 -1.04% 14.58% 950K
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.